Patent · US Active

Substituted spirooxindoles

US9822128B1 · kind B1 · utility

2Cited by
1References
3Claims
0Family size

Inventors

Key dates

Filing dateJun 1, 2017
Grant dateNov 21, 2017
Priority date
Expiry dateJun 1, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/20
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The substituted spirooxindoles are MDM2-p53 inhibitors bearing a benzylidine (styryl) arm and have a complex fused ring system ideally suited for binding to the MDM2 protein, thereby interrupting its protein-protein interaction (PPI). Sixteen compounds, designated 4a-4p, were synthesized in a simple smooth method using an asymmetric 1,3-dipolar reaction as the key step. Testing showed that the compounds exhibit anti-cancer activity against various forms of cancer cells affecting humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.